Bosulif (bosutinib tablets and capsules) — Cigna

Initial criteria

• Patient age ≥ 15 years
• Patient has Philadelphia chromosome-positive acute lymphoblastic leukemia
• Patient has tried at least one other tyrosine kinase inhibitor for Philadelphia chromosome-positive acute lymphoblastic leukemia

Approval duration

1 year